Regarding to the biological markers, which can predict disease prognosis and treatment outcomes, the genotypes were similarly distributed irrespective of the status of ER, PR, erbB2 and Ki67, neither do the receptor status or triple-negative breast cancer. Here, ERBB2 is linked to triple-negative breast carcinoma.